FAQ/Help |
Calendar |
Search |
Today's Posts |
04-05-2007, 08:35 AM | #1 | |||
|
||||
Magnate
|
PDTrials.org
Study of CERE-120 in People with Parkinson’s Disease Official Study Title: Randomized, Double-Blind, Sham Surgery-Controlled Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) to Assess the Efficacy and Safety of Bilateral Intraputaminal (IPu) Delivery in Subjects with Idiopathic Parkinson’s Disease http://www.pdtrials.org/front/trial_...p?trial_id=128 ClinicalTrials.gov Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 For Efficacy and Safety in Subjects With Idiopathic Parkinson's Disease This study is currently recruiting patients. Verified by Ceregene March 2007 http://clinicaltrials.gov/show/NCT00400634 Recombinate DNA Advisory Committee Meeting Minutes September 2006 http://www4.od.nih.gov/oba/RAC/minut...utes_09-06.pdf PowerPoint Presentation CERE-120 (AAV-Neurturin) for Parkinson’s Disease NIH OBA Protocol # 0501-689 A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN] to Assess the Safety and Tolerability of Intrastriatal Delivery to Subjects with Idiopathic Parkinson's Disease http://www.webconferences.com/nihoba...des16Mar05.pdf
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
B 12 information | Multiple Sclerosis | |||
need information | Meralgia Paresthetica | |||
Ceregene | Parkinson's Disease | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease | |||
CERE-120 Phase II trials fall of 2006 | Parkinson's Disease |